Real-World Biologic Use Patterns in Severe Asthma, 2015–2021: The CLEAR Study

Switching or stopping biologic therapy was associated with worse clinical outcomes than continuing the initial therapy.

Authors

Lakmini Bulathsinhala (ORCID: https://orcid.org/0009-0007-0466-4671)
Cono Ariti (ORCID: https://orcid.org/0000-0001-7615-0935)
Benjamin Emmanuel (ORCID: https://orcid.org/0000-0003-1769-9826)
Chau‐Chyun Sheu (ORCID: https://orcid.org/0000-0002-7979-3749)
Trung N. Tran (ORCID: https://orcid.org/0000-0001-8003-7601)
Flavia Hoyte (ORCID: https://orcid.org/0000-0002-0426-6362)
ARNAUD AB BOURDIN (ORCID: https://orcid.org/0000-0002-4645-5209)
Alan Altraja (ORCID: https://orcid.org/0000-0001-7798-9871)
William Henley (ORCID: https://orcid.org/0000-0001-6273-2619)
Celine Goh (ORCID: https://orcid.org/0000-0002-4571-8468)
David Price (ORCID: https://orcid.org/0000-0002-9728-9992)
Victoria Carter (ORCID: https://orcid.org/0000-0002-0333-3308)
Anna Quinton (ORCID: https://orcid.org/0009-0006-4563-7533)
Stephanie Chen (ORCID: https://orcid.org/0009-0009-2415-1499)
Ming‐Ju Tsai (ORCID: https://orcid.org/0000-0003-3621-3334)
Yang Liu (ORCID: https://orcid.org/0000-0001-5834-9318)
Bill Cook